The effect of elevated muscle pain on neuromuscular fatigue during exercise by Norbury, Ryan et al.
Kent Academic Repository
Full text document (pdf)
Copyright & reuse
Content in the Kent Academic Repository is made available for research purposes. Unless otherwise stated all
content is protected by copyright and in the absence of an open licence (eg Creative Commons), permissions 
for further reuse of content should be sought from the publisher, author or other copyright holder. 
Versions of research
The version in the Kent Academic Repository may differ from the final published version. 
Users are advised to check http://kar.kent.ac.uk for the status of the paper. Users should always cite the 
published version of record.
Enquiries
For any further enquiries regarding the licence status of this document, please contact: 
researchsupport@kent.ac.uk
If you believe this document infringes copyright then please contact the KAR admin team with the take-down 
information provided at http://kar.kent.ac.uk/contact.html
Citation for published version
Norbury, Ryan, Smith, Samuel A., Burnley, Mark, Judge, Megan and Mauger, Alexis R.   (2021)
The effect of elevated muscle pain on neuromuscular fatigue during exercise.   European Journal
of Applied Physiology .    ISSN 1439-6319.
DOI
https://doi.org/10.1007/s00421-021-04814-1





European Journal of Applied Physiology 
https://doi.org/10.1007/s00421-021-04814-1
ORIGINAL ARTICLE
The effect of elevated muscle pain on neuromuscular fatigue 
during exercise
Ryan Norbury1  · Samuel A. Smith1  · Mark Burnley1  · Megan Judge1  · Alexis R. Mauger1 
Received: 3 March 2021 / Accepted: 15 September 2021 
© The Author(s) 2021
Abstract
Purpose Muscle pain can impair exercise performance but the mechanisms for this are unknown. This study examined the 
effects of muscle pain on neuromuscular fatigue during an endurance task.
Methods On separate visits, twelve participants completed an isometric time-to-task failure (TTF) exercise of the right 
knee extensors at ~ 20% of maximum force following an intramuscular injection of isotonic saline (CTRL) or hypertonic 
saline (HYP) into the vastus lateralis. Measures of neuromuscular fatigue were taken before, during and after the TTF using 
transcranial magnetic stimulation (TMS) and peripheral nerve stimulation.
Results The mean pain intensity was 57 ± 10 in HYP compared to 38 ± 18 in CTRL (P < 0.001). TTF was reduced in HYP 
(4.36 ± 0.88 min) compared to CTRL (5.20 ± 0.39 min) (P = 0.003). Maximum voluntary force was 12% lower at minute 1 
(P = 0.003) and 11% lower at minute 2 in HYP (P = 0.013) compared to CTRL. Voluntary activation was 4% lower at minute 
1 in HYP compared to CTRL (P = 0.006) but not at any other time point (all P > 0.05). The TMS silent period was 9% longer 
at 100 s during the TTF in HYP compared to CTRL (P = 0.026).
Conclusion Muscle pain reduces exercise performance through the excacerbation of neuromuscular fatigue that is central in 
origin. This appears to be from inhibitory feedback from group III/IV nociceptors which acts to reduce central motor output.
Keywords Muscle pain · Neuromuscular fatigue · Isometric performance · Central fatigue · Transcranial magnetic 
stimulation
Abbreviations
ANOVA  Analysis of variance
BF  Biceps femoris
CTRL  Control condition
EMG  Electromyography
HYP  Hypertonic saline condition
MEPAMP  Motor-evoked potential amplitude
MVC  Maximum voluntary contraction
MVF  Maximim voluntary force
PANAS  Positvie and negative affect schedule
RMS  Root mean square
RPE  Rating of perceived exertion
TMS  Transcranial magnetic stimulation
TTF  Time to task failure
VAS  Visual analogue scale
VL  Vastus lateralis
VM  Vastus medialis
Introduction
Exercise requires repeated or sustained muscular contrac-
tions and can cause a progressive decline in the force-gen-
erating capacity of a muscle, known as exercise-induced 
fatigue (Gandevia 2001). The aetiology of exercise-induced 
fatigue can be central (changes at the spinal or supraspinal 
level) and/or peripheral (changes at or distal to the neuro-
muscular junction) in origin (Bigland Ritchie et al. 1978; 
Kent-Braun 1999) but most exercise appears to encompass 
both types of fatigue in a feedback–feedforward system to 
regulate exercise tolerance (Hureau et al. 2018).
Strenuous exercise is usually accompanied by exercise-
induced pain. Pain can be defined as an unpleasant sensory 
and emotional experience associated with, or resembling 
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that associated with, actual or potential tissue damage (Raja 
et al. 2020). The naturally occurring and non-damaging 
exertional pain accompanying strenuous exercise (exercise-
induced pain) can be described as “aching” or “cramping” 
and increases as a function of time/exercise intensity (Cook 
et al. 1997; Smith et al. 2020). The feeling of exercise-
induced pain arises from the accumulation of noxious bio-
chemicals, reduced muscle pH and increases in intramus-
cular pressure which consequently stimulates group III/IV 
nociceptive afferents (O’Connor and Cook 1999; Mense 
2008). Since exercise-induced pain and exercise intensity 
(and consequently the development of fatigue) are associ-
ated, it may be possible that exercise-induced pain contrib-
utes to the fatigue process, however this is not known.
Previous work has found that in combination with tradi-
tional physiological parameters (e.g. lactate threshold), pain 
tolerance (i.e. the maximum level of perceived pain someone 
can tolerate) can partially predict cycling time-trial perfor-
mance (Astokorki and Mauger 2017a) and that reducing 
muscle pain through the ingestion of acetaminophen results 
in an improvement in endurance performance (Mauger et al. 
2010; Foster et al. 2014; Astokorki and Mauger 2017b; Mor-
gan et al. 2019). Conversely, elevating muscle pain through 
the intramuscular injection of hypertonic saline has been 
shown to reduce isometric TTF performance (Graven-
Nielsen et al. 1997b; Ciubotariu et al. 2004; Smith et al. 
2020) and maximum muscle strength (Graven-Nielsen et al. 
2002; Slater et al. 2003; Khan et al. 2011). The mechanisms 
which underpin these changes are suggested to be centrally 
mediated (Le Pera et al. 2001; Schabrun and Hodges 2012) 
but the fatiguing effect of pain during exercise is unclear. 
Additionally, the experience of muscle pain may reduce 
endurance performance by acting as an aversive stimulus 
which causes a voluntary disengagement from exercise or 
reduction in exercise intensity. On the other hand, muscle 
pain may independently cause fatigue by altering motor unit 
recruitment thresholds/firing rates or reducing central motor 
drive and act on a physiological, unconscious basis (i.e., the 
nociceptive component).
Recently, Smith et al. (2020) induced muscle pain using 
an intramuscular injection of hypertonic saline during sub-
maximal isometric knee extensor exercise. They found that 
this produced a similar pain quality to exercise-induced pain 
and allowed the authors to decouple the pain-intensity rela-
tionship during knee extensor exercise. The increased mus-
cle pain caused a mean decrease of 26% in endurance time, 
despite a similar end-exercise maximum voluntary torque, 
which suggests that fatigue occurred more rapidly when pain 
was exacerbated.
The use of peripheral nerve stimulation allows for the 
measurement of peripheral changes in muscle function (e.g. 
resting twitch amplitude) as well as central changes in vol-
untary activation (via the interpolated twitch technique). 
Transcranial magnetic stimulation (TMS) allows for the 
non-invasive quantification of corticospinal excitability and 
inhibition during exercise and in combination would provide 
novel information on the development of neuromuscular 
fatigue in response to elevated muscle pain. Consequently, 
these methods allow us to further understand the mecha-
nisms of how muscle pain may act to limit endurance per-
formance as opposed to isolated measures of motor function 
that have previously been explored (e.g. Le Pera et al. 2001; 
Khan et al. 2011).
Therefore, the purpose of this study was to perform an 
isometric TTF of the knee extensors with elevated muscle 
pain from an intramuscular injection of hypertonic saline 
while simultaneously recording measures of neuromuscular 
fatigue to identify the mechanisms behind how muscle pain 
limits endurance performance. It was hypothesised that the 
intramuscular injection of hypertonic saline would decrease 
isometric TTF through an exacerbation of central fatigue 
(i.e., decreased voluntary activation).
Methods
Participants
Twelve healthy and recreationally active individuals (two 
female) with a mean ± SD age 26.6 ± 3.9 years, height: 
175 ± 8.2 cm, body mass: 72.2 ± 11.7 kg volunteered to take 
part in the study. All participants had no lower-limb injury 
within the past three months, were not taking medication 
for the treatment of pain or had any pain related conditions. 
Participants were also screened for any contraindications 
to TMS. All participants provided written informed con-
sent before testing. The study was approved by the Univer-
sity of Kent SSES Research Ethics Advisory Group (Prop 
30_2018_2019) and was conducted in alignment with the 
declaration of Helsinki.
Experimental protocol
Participants visited the laboratory on four occasions sepa-
rated by a minimum of 48 h between visits 1 and 2 and at 
least 7 days between visits 3 and 4. Participants performed 
the experiment at a similar time of day (± 1.5 h) and avoided 
strenuous physical activity 48 h, caffeine 4 h, alcohol 24 h 
and analgesics 6 h prior to testing. In visit one, participants 
were familiarised with measures of neuromuscular func-
tion (see neuromuscular function testing), questionnaires, 
perceptual measures, the isometric TTF exercise and the 
intramuscular injection of hypertonic saline if they had not 
received one before. Visit two composed of a second famil-
iarisation of the isometric exercise task where the intensity 
(%MVC) was adjusted from the first visit if the TTF was not 
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within 4–6 min. This was to ensure that the isometric time-
to-task failure coincided with the typical pain duration from 
the intramuscular injection of hypertonic saline into the vas-
tus lateralis (VL) (Smith et al. 2020). Visits three and four 
were experimental visits (Fig. 1) completed in a randomised 
order. Participants arrived at the laboratory and completed 
the positive and negative affect schedule (PANAS) and pain 
expectation/pain-coping confidence. They then underwent 
baseline measures of neuromuscular function involving 
peripheral neve stimulation and single pulse TMS during 
isometric contractions of the right knee extensors. Partici-
pants then waited 10 min before receiving an intramuscular 
injection of 1 mL of isotonic saline (0.9%) or hypertonic 
saline (5.85%) in the muscle belly of the VL. The isotonic 
saline condition served as a non-painful injection matched 
control (CTRL) while the hypertonic saline caused acute 
muscle pain (HYP). Immediately after the injection, par-
ticipants began the submaximal isometric TTF protocol 
with intermittent measures of peripheral nerve stimulation 
and TMS while providing measures of pain and RPE until 
task failure, where post-exercise measures of neuromuscular 
fatigue were performed along with the pain catastrophiz-




A single bolus of 1 mL hypertonic saline (5.85% NaCl) was 
injected in the VL (the middle third of the muscle belly) of 
the right leg to induce muscle pain. The site was cleaned 
with an alcohol swab and then the saline was manually 
injected using a 3 mL Luer-Lok syringe (BD, New Jersey, 
USA) connected to a 1.5 inch 25-gauge hypodermic nee-
dle (SurGuard2, Terumo, Japan) over a 20 s window (5 s 
pause after the insertion, a 10 s infusion period, followed 
by 5 s pause before needle withdrawal). An identical injec-
tion protocol was performed with the isotonic saline (CTRL 
condition).
Exercise protocol
The exercise protocol was a semi-constant submaximal iso-
metric TTF of the right knee extensors at an individualised 
intensity to cause TTF within 4–6 min in CTRL. The mean 
intensity for the participants was 20% of maximum volun-
tary force (MVF), but this ranged from 13 to 25% of MVF. 
Three seconds before the end of each minute in the TTF 
exercise, participants were instructed to relax and prepare 
to perform an MVC with superimposed doublet and subse-
quently relax for 3 s while a resting doublet was delivered. 
Four TMS pulses and a single peripheral nerve stimulation 
was delivered during the submaximal contraction phase of 
the TTF task at 10 s and 100 s. Participants were encour-
aged to go for as long as possible until they were unable to 
maintain the target for three consecutive seconds or volun-
tarily withdrew from the task. Participants also continuously 
rated their pain and provided RPE every minute and at task 
failure. A schematic of the experimental protocol can be 
seen in Fig. 1.
Mechanical recordings
Participants were strapped into a custom-built isomet-
ric chair with a hip and knee angle of 90° (0° being full 
Fig. 1  Schematic of the experimental visits CTRL and HYP. EMG electromyography, VL vastus lateralis, VM vastus medialis, BF biceps femo-
ris, VAS visual analogue scale, NMF neuromuscular function
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extension). Straps secured the participant around the torso to 
prevent any extraneous movement and a non-compliant strap 
was secured 2 cm above the malleoli which was connected 
to a transducer to measure isometric force of the knee exten-
sors. The transducer was connected to a signal amplifier 
(DA100c, Biopac Systems Inc, California, USA) and data 
acquisition module (MP150, Biopac Systems Inc, California, 
USA) and sampled at a frequency of 1.25 kHz in compatible 
software (Acqknowledge 5.0, Biopac Systems, California, 
USA). Force traces providing instantaneous feedback were 
displayed on a computer screen in view of the participant.
Electromyography (EMG)
Bipolar surface electromyography was used to record activ-
ity of the VL, vastus medialis (VM) and biceps femoris (BF) 
with 37.5 mm × 37.5 mm Ag/AgCl electrodes (Whitesensor 
4831Q, Ambu Ltd, Denmark) at an inter electrode distance 
of 37.5 mm. The VL electrodes recorded evoked responses 
from TMS and peripheral nerve stimulation and volun-
tary muscle activity whereas the VM was used to assess 
changes in synergist activity in response to muscle pain. The 
BF measures were used to check and minimise antagonist 
motor-evoked potential amplitudes.
The electrode location was on the muscle belly proximal 
to the knee and parallel to the fibres of the muscle for the 
VL and VM while the BF was placed on the muscle belly 
50% of the distance between the ischial tuberosity and the 
lateral epicondyle of the tibia. Each site was shaved, abraded 
and cleaned to reduce impedance and the electrode locations 
were marked for replication in subsequent visits. All EMG 
data were recorded continuously at a frequency of 2.5 kHz 
and amplified (gain 1000 for VL, 2000 for VM and BF) 
with a signal amplifier (EMG2-R, Biopac Systems, Califor-
nia, USA and EMG100c, Biopac Systems, California, USA) 
before being band pass-filtered (10–500 Hz) and recorded 
onto compatible software (Acqknowledge v5.0, Biopac sys-
tems, California, USA).
Peripheral nerve stimulation
An electrical stimulator (DS7r, Digitimer, Hertford-
shire, UK) (maximum voltage = 400 v) capable of deliv-
ering a single square wave pulse was used for peripheral 
nerve stimulation. The anode was an adhesive electrode 
(100 mm × 50 mm; Phoenix Healthcare Products Ltd, Not-
tingham, UK) which was secured at the gluteal fold. Initially, 
the cathode was a motor-point pen (Motor Point Pen; Com-
pex; DJO Global, Guildford, UK) which was placed over the 
femoral nerve. The motor-point pen was used to identify the 
precise location which evoked the largest twitch force and 
compound muscle action potential (M-wave) peak-to-peak 
amplitude. A 32 × 32 mm electrode was attached to this site 
(Nessler Medizintechnik, Innsbruck, Austria) to ensure the 
same area was stimulated for all subsequent stimulations. 
This process was repeated on every experimental visit. To 
determine the intensity required to achieve supramaximal 
stimulation, 20 mA stepwise increments in stimulation inten-
sity were delivered from 100 mA until a plateau in twitch 
force and M-Wave amplitude was observed. An additional 
30% was added to ensure supramaximal stimulation (Mmax). 
This intensity was used throughout the rest of the respective 
trial. Doublets were delivered as 100 Hz paired stimuli (1 ms 
pulse duration) for the assessment of central and peripheral 
fatigue (see below data analysis), whereas single stimulus 
(2 ms pulse duration) was delivered for the normalisation of 
motor-evoked potentials.
Transcranial magnetic stimulation
Single-pulse TMS was delivered with a magnetic stimulator 
(Magstim  2002, The Magstim Company Ltd, Carmarthen-
shire, UK) via a double cone coil (110 mm diameter) deliv-
ering a posterior–anterior current which was placed over the 
motor cortex to assess corticospinal excitability of the right 
quadriceps. Initially the participant’s vertex was marked as 
the midpoint between the nasal-inion and the tragus. The 
coil was initially placed 2 cm laterally to this position. Stim-
uli were superimposed over a submaximal contraction (same 
as target force for subsequent exercise ~ 20% of maximum 
force) of the knee extensors at 50% of maximal stimula-
tor output until the hotspot (the location which provided 
the greatest peak-to-peak EMG amplitude of the motor-
evoked potential  [MEPAMP] in the VL while minimising the 
 MEPAMP of the BF (to ensure optimal coil placement) was 
found. This location was marked onto a skin-tight hat the 
participant was wearing. The participant also wore a cervical 
collar to prevent excessive movement of the head. Subse-
quent TMS pulses were delivered in trains of four stimuli 
separated by approximately 3 s which were superimposed 
over the submaximal knee extensor contraction. Trains of 
stimuli were separated by approximately 20 s during base-
line. Stepwise increments in the stimulator intensity of 5% 
were used until a plateau in the average of the four MEPs 
was reached (< 5% increase). This was 67 ± 5% of maximum 
stimulator output in CTRL and 66 ± 7% in HYP. Each train 
of TMS pulses was accompanied by the delivery of a single 
peripheral nerve stimulation to acquire MEP/Mmax ratio.
Perceptual measures
To assess the quantity of pain, an electronic visual analogue 
scale displayed the pain perception scale (Cook et al. 1997) 
and allowed participants to continuously rate their muscle 
pain. The device automatically recorded a pain reading every 
2 s based on the position of the slider marker and recorded 
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the data on an SD card. The scale ranged from 0 which cor-
responded to ‘no pain at all’ to 100 which corresponded to 
‘extremely intense pain (almost unbearable)’. Participants 
were instructed to anchor the upper pain ratings to the worst 
exercise-induced pain they had previously experienced 
(Astokorki and Mauger 2017b). Rating of perceived effort 
(RPE) was recorded on the 6–20 point scale (Borg 1998) to 
avoid participants conflating pain and effort ratings. Instruc-
tions were also given to participants to exclusively rate their 
effort based on the ‘effort to drive the limb’ with a rating of 
20 anchored to the level of drive given during the maximum 
voluntary contraction performed prior (Pageaux 2016).
Questionnaires
Before each experimental visit, the PANAS (Watson et al. 
1988) was administered to confirm participants arrived 
at the lab in a similar psychologoical state. Additionally, 
pain expectation from 0 to 10 (0 = ‘no pain’ and 10 = ‘worst 
possible pain’) and perceived pain-coping ability (0 = ‘not 
confident at all’ and 10 = ‘completely confident’) were 
recorded. The situation-specific pain catastrophizing scale 
(Edwards et al. 2006) and the long form McGill pain ques-
tionnaire (Melzack 1975) were administered immediately 
post exercise.
Neuromuscular function testing
For baseline measures of neuromuscular function, par-
ticipants initially performed a warmup consisting of ten 
contractions at 50% of perceived maximum effort (3 s con-
tracting, 3 s relaxing). This was followed by four maximum 
voluntary contractions of 4 s in duration separated by 2 min 
of rest. On the third and fourth MVC, a superimposed dou-
blet was delivered once peak force was reached and a resting 
potentiated doublet was delivered within 5 s of the end of 
the MVC. Twelve TMS stimuli were delivered during twelve 
submaximal contractions (3 sets of 4 contractions) at the 
target force of the subsequent exercise. One single periph-
eral nerve stimulation was delivered during a contraction 
after the final contraction with TMS. Post exercise (within 
10 s), a single MVC with peripheral neve stimulation was 
delivered followed by four submaximal contractions super-
imposed with TMS and one contraction superimposed with 
single peripheral nerve stimulation to measure corticospinal 
excitability and inhibition.
Data analysis
The baseline neuromuscular variables were calculated as 
the mean raw value and the raw value was taken for each 
measure during every minute. MVF and doublet amplitude 
were recorded as the peak instantaneous force achieved. 
Voluntary activation, a measure of central fatigue, was cal-
culated using the interpolated twitch technique with the Stro-
jnik and Komi (1998) correction applied where necessary, 
with VA calculated as:
The average MEP peak-to-peak amplitude was normal-
ised to the most proximal peak-to-peak amplitude of the 
M-Wave to get MEP/Mmax. The TMS silent period was 
determined as the duration from the point of stimulation 
(i.e. stimulation artefact) until the return of the EMG sig-
nal which was visually inspected by the same investigator. 
The root mean square (RMS) of the EMG waveform was 
calculated offline in software (Acqknowledge V5.0; Biopac 
systems Inc, California, USA) using a 100 ms time constant. 
The mean 500 ms of the RMS (250 ms either side of peak 
force) was analysed for MVCs and the mean 20 s of data 
was analysed at the beginning of each minute and before 
task failure of the exercise task and was normalised to MVC 
EMG amplitude. The ΔMVF, ΔVAL, ΔDoublet, ΔSilent 
period/ΔTime were calculated as the change in value from 
pre- to post-exercise divided by the TTF as an indicator of 
the rate of fatigue development.
Pain data were taken as the VAS recorded at every 20 s 
and at task failure.
Statistical analysis
All data are presented as mean ± SD or a mean and inter-
quartile range when not normally distributed. Data were ana-
lysed in JAMOVI 1.0.7.0. (The Jamovi Project, 2020). Data 
were initially checked for normality with the Shapiro–Wilk 
test and sphericity with the Mauchly test. If these assump-
tions were violated, data were analysed with a non-para-
metric test or Greenhouse–Geiser corrected, respectively. 
A paired samples t test was used to compare TTF between 
CTRL and HYP. A 2 × 4 repeated measures ANOVA (con-
dition × time) was used to analyse neuromuscular variables 
at baseline, minute one, two (or 10 s and 100 s for TMS 
data) and task failure. A 2 × 8 repeated measures analysis 
of variance (ANOVA) was used to analyse pain VAS data. 
Follow-up paired samples t tests were used to determine 
differences between conditions at different time points and 
were Bonferroni–Holm-corrected where appropriate (Holm 
1979). Paired samples t tests were used for differences in 
TTF and the ΔMVF, ΔVAL, ΔDoublet, ΔSP/ΔTime which 
were Bonferroni-corrected. Intraclass correlation coeffi-
cients (2,1) were calculated and presented as point estimate 
and 95% confidence interval for doublet amplitude between 
CTRL ansd HYP at minute one, two and task failure for 
confirmation of similarity.
100 − SI Doublet ×
(force before SI doublet/peakforce)
resting potentiated doublet
× 100.
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95% confidence intervals, Cohen’s d effect sizes (Cohen 
1992) and partial eta-squared ( η2
p
 ) were reported where 
appropriate. A Pearson correlations matrix was used to 
examine the relationship between changes in pain at minute 
1 between conditions against change in neuromuscular vari-




There was a 16.2% shorter TTF in HYP (4.36 ± 0.88 min) 
compared to CTRL (5.20 ± 0.39  min) (mean differ-
ence = 0.84  min, 95% CI [0.34, 1.33  min], t11 = 3.728, 
P = 0.003, dz = 1.08) (Fig. 2).
Pain intensity and pain quality
Prior to each experimental visit, there was no difference in 
pain expectation (P = 0.602) or pain-coping confidence (Wil-
coxon P = 1.000). The mean pain intensity, matched for exer-
cise time, was greater in HYP (57 ± 10) compared to CTRL 
(38 ± 18) (mean difference = 19, 95% CI [11, 28], t11 = 5.18, 
P < 0.001, dz = 1.50). When also matched for exercise time, 
peak pain was greater in HYP (94.5 [75.8–99.3]) compared 
to CTRL (85.5 [55.8–99.0]) (Wilcoxon P = 0.047). For pain 
intensity throughout the TTF, there was a condition × time 
interaction (F3.42, 37.59 = 10.7, P < 0.001, η2p = 0.493) (Fig. 2). 
Pain intensity was elevated from 20 to 140 s (all P < 0.001) 
in HYP compared to CTRL but was not different between 
conditions at 0 s (P = 0.142) or at task failure (P = 1.000) 
(Fig. 2). For pain quality assessed by the McGill long form 
questionnaire, Cramping (50%), Aching (58%), Tiring (58%) 
and Intense (50%) were the most common words selected in 
CTRL whereas in HYP, Cramping (50%), Aching (42%), 
Grueling (42%), Intense (67%) were most selected. No dif-
ference was seen in the total pain rating (P = 0.466) or the 
sensory (P = 0.686), affective (P = 0.515), evaluative (Wil-
coxon P = 0.269) or miscellaneous (P = 0.160) dimensions 
of pain.
Maximum voluntary force (MVF)
For MVF, there was a condition × time interaction 
(F1.77, 19.43 = 6.81, P = 0.007, η2p = 0.382). Subsequent post 
hoc tests revealed that MVF decreased by 43% (mean differ-
ence = 278 N, 95% CI [218, 338 N], t11 = 14.09, P < 0.001, 
dz = 2.96) and 45% (mean difference = 293 N, 95% CI [244, 
342 N], t11 = 14.85, P < 0.001, dz = 3.78) in CTRL and HYP, 
respectively, with no difference between conditions 
(P > 0.999). However, during the exercise task, MVF was 
lower at minute 1 in HYP (509 ± 139 N) compared to CTRL 
(577 ± 155 N) (mean difference = 68 N, 95% CI [26, 109 N], 
t11 = 4.001, P = 0.003, dz = 1.02). Similarly, MVF at minute 
2 was lower in HYP (470 ± 124 N) compared to CTRL 
(527 ± 141 N) (mean difference = 56 N, 95% CI [10, 102 N], 
t11 = 3.334, P = 0.013, dz = 0.78) (Fig. 3.). The change in 
ΔMVF/ΔTime was greater in HYP than in CTRL (Wilcoxon 
P = 0.015) (CTRL = 52 [43–63] N  min−1, HYP = 67 [56–81] 
N  min−1).
Voluntary activation (VA)
No interaction effect was observed for VA (F1.56, 17.18 = 1.34, 
P = 0.282, η2
p
 = 0.108). However, there was a main effect of 
condition (F1.11, = 7.60, P = 0.019, η2p = 0.409). Post hoc tests 
revealed that VA was lower in HYP (92.2 ± 5.1%) than 
CTRL (96.4 ± 2.5%) at minute 1 (mean difference = 4.2%, 
95% CI [1.44, 6.9%], t11 = 3.36, P = 0.006, dz = 0.97) but was 
not different at minute 2 (mean difference = 4.3%, 95% CI 
[− 0.2%, 8.8%], t11 = 2.08, P = 0.061, dz = 0.60) or at task 
failure (mean difference = 6.5%, 95% CI [− 0.5%, 13.5%], 
t11 = 2.04, P = 0.066, dz = 0.59). There was also a main effect 
of time for VA (F1.45, 15.91 = 17.31, P < 0.001, η2p = 0.611). 
VA decreased from 95.8 to 85.9% in CTRL (mean differ-
ence = 9.9%, 95% CI [6.1, 13.8%], t11 = 4.047, P = 0.003, 
Fig. 2  A TTF of the isometric 
endurance task. Data presented 
as mean ± SD and individual 
data. *Denoted significantly 
different from CTRL (P < 0.05). 
B Pain VAS data through the 
isometric TTF. Data presented 
as mean ± SD. **Denotes sig-
nificantly different from CTRL 
(P < 0.001)
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dz = 1.64) and from 96.1% to 79.4% in HYP (mean differ-
ence = 16.69%, 95% CI [7.8, 25.5%], t11 = 6.807, P < 0.001, 
dz = 1.20). There was a greater ΔVAL/ΔTime in HYP 
(3.9 ± 3.0%  min−1) compared to CTRL (1.9 ± 1.2%  min−1) 
(P = 0.036).
Doublet amplitude and Mmax
For doublet amplitude, there was no condition x time inter-
action (F1.48, 16.24 = 0.346, P = 0.649, η2p = 0.030) or main 
effect of condition (F1, 11 = 1.578, P = 0.235, η2p = 0.125). 
However, there was a main effect of time (F1.07, 11.80 = 22.136, 
P < 0.001, η2
p
 = 0.668). Doublet amplitude decreased by 34% 
in CTRL (mean difference = 106 N, 95% CI [64, 148 N], 
t11 = 7.725, P < 0.001, dz = 1.60) and by 33% in HYP (mean 
difference = 103  N, 95% CI [57, 149  N], t11 = 7.510, 
P < 0.001, dz = 1.43) (Fig. 3). There was no difference in the 
ΔDoublet/ΔTime (P = 0.218). Intraclass correlation coeffi-
cients for doublet amplitude were 0.935 (0.795–0.981), 
0.948 (0.836–0.985) and 0.944 (0.819–0.984). For Mmax, 
there was no condition × time interaction (F3, 33 = 1.360, 
P = 0.272, η2
p
 = 0.110) or main effect of condition 
(F1, 11 = 0.074, P = 0.790, η2p = 0.007) and time 
(F1.90, 20.91 = 3.26, P = 0.061, η2p = 0.229).
MEP/Mmax
For  MEPAMP, no condition × time interaction was observed 
(F1.69, 18.54 = 0.370, P = 0.660, η2p = 0.033) or main effect of 
condition F1, 11 = 2.411, P = 0.149, η2p = 0.180). There was a 
main effect of time (F3, 33 = 3.942, P = 0.017, η2p = 0.264) for 
an increase in MEP/Mmax but subsequent post hoc tests with 
a Holm–Bonferroni-correction revealed no significant 
differences.
Silent period
There was no condition × time interaction for silent period 
(F2.08, 22.85 = 1.84, P = 0.181, η2p = 0.143). However, there 
was a main effect of time (F1.24, 13.66 = 10.56, P = 0.004, η2p 
= 0.490) and condition (F1, 11 = 6.47, P = 0.027, η2p = 0.370). 
Silent period increased by 28% in CTRL (mean differ-
ence = 40 ms, 95% CI [9, 72 ms], t11 = 3.368, P = 0.031, 
dz = 0.81) and by 36% in HYP (mean difference = 51 ms, 
95% CI [15, 87 ms], t11 = 4.304, P = 0.003, dz = 0.91) but 
was not different between conditions (mean differ-
ence = 13 ms, 95% CI [− 5, 31 ms], t11 = 1.60, P = 0.138, 
dz = 0.46). A longer silent period was observed at the 100 s 
time point (mean difference = 17 ms, 95% CI [2, 31 ms], 
t11 = 2.57, P = 0.026, dz = 0.74), but not at 10 s (mean differ-
ence = 5 ms, 95% CI [− 3, 14 ms], t11 = 1.42, P = 0.183, 
dz = 0.41) (Fig. 3).
Electromyography
Vastus lateralis
For  EMGRMS amplitude of the VL during MVCs, there was 
a condition × time interaction (F2, 22 = 4.74, P = 0.019, η2p = 
Fig. 3  Neuromuscular fatigue 
variables at each minute of the 
isometric TTF. A Maximum 
voluntary force. B Voluntary 
activation level. C Doublet 
Amplitude. D Silent Period 
during the MVCs. *Denotes sig-
nificantly different from CTRL 
(P < 0.05). #Denotes signifi-
cantly different from baseline 
(P < 0.05)
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0.301).  EMGRMS was lower at minute 1 (mean differ-
ence = 24.8%, 95% CI [12.6, 37.1%], t11 = 4.978, P < 0.001, 
dz = 1.29) and minute 2 (mean difference = 15.1%, 95% CI 
[4.0, 26.1%], t11 = 3.024, P = 0.044, dz = 0.87) in HYP com-
pared to CTRL. No difference was seen at task failure (mean 
difference = 4.4%, 95% CI [− 5.1, 13.8%], t11 = 0.877, 
P = 1.000, dz = 0.29).  EMGRMS decreased in CTRL from 
minute 1 to task failure (mean difference = 31.9%, 95% CI 
[14.4, 49.4%], t11 = 5.180, P < 0.001, dz = 1.16) but not it 
HYP (P = 0.500). For EMG amplitude during the submaxi-
mal TTF, there was a condition × time interaction 
(F1, 11 = 5.018, P = 0.047, η2p = 0.313).  EMGRMS was not dif-
ferent at minute 1 (mean difference = 1.1%, 95% CI [-1, 
3.1%], t11 = 0.743, P = 0.465, dz = 0.33).  EMGRMS increased 
in amplitude at task failure for both conditions, however, 
 EMGRMS was lower in HYP compared to CTRL (mean dif-
ference = 5.2%, 95% CI [1.3, 9.2%], t11 = 3.795, P = 0.011, 
dz = 0.84) (Fig. 4).
Vastus medialis
For  EMGRMS amplitude of the VM during MVCs, there was 
no condition × time interaction (F2, 22 = 3.20, P = 0.060, η2p 
= 0.225). However, there was a main effect of condition 
(F1, 11 = 8.58, P = 0.014, η2p = 0.225). MVC  EMGRMS ampli-
tude was lower at minute 1 (mean difference = 20.7%, 95% 
CI [5.7, 35.7%], t11 = 3.04, P = 0.033, dz = 0.88) and minute 
2 (mean difference = 21.2%, 95% CI [3.8, 38.8%], t11 = 2.68, 
P = 0.042, dz = 0.77) but not different at the task failure 
MVC (mean difference = 8.0%, 95% CI [− 2.5, 18.5%], 
t11 = 1.67, P = 0.123, dz = 0.48). There was also a main effect 
of time (F1.253, 13.779 = 15.49, P < 0.001, η2p = 0.585). MVC 
 EMGRMS decreased from minute 1 to task failure in CTRL 
(mean difference = 29.4%, 95% CI [13.5, 45.4%], t11 = 5.17, 
P < 0.001, dz = 1.17) and in HYP (mean difference = 16.7%, 
95% CI [7.8, 25.6%], t11 = 3.69, P = 0.004, dz = 1.20). For 
 EMGRMS amplitude during the submaximal TTF, there was 
no condition × time interaction (F1, 11 = 3.401, P = 0.092, η2p 
= 0.236) or main effect of condition (F1, 11 = 2.355, 
P = 0.153, η2
p
 = 0.176). There was a main effect of time 
(F1, 11 = 8.705, P = 0.013, η2p = 0.442).  EMGRMS increased 
from minute 1 to task failure in CTRL (mean differ-
ence = 21.0%, 95% CI [5.6, 36.3%], t11 = 3.005, P = 0.012, 
dz = 0.87) and in HYP (mean difference = 16.8%, 95% CI 
[3.6, 30.0%], t11 = 2.807, P = 0.017, dz = 0.81) (Fig. 4).
Correlations
A Pearson correlation matrix with a Bonferroni correc-
tion revealed a significant negative relationship between 
the change in mean pain VAS from CTRL to HYP of min-
ute 1, against the change in MVF (r = -0.859, P = 0.001) 
and VAL (r = − 0.773, P = 0.013) but not between doublet 
amplitude (r = − 0.174, P = 1.000) or MVC EMG amplitude 
(r = − 0.344, P = 1.000) between conditions (Fig. 5).
Rating of perceived effort
For RPE, there was a condition × time interaction 
(F2, 22 = 12.6, P < 0.001, η2p = 0.553). RPE increased over 
Fig. 4  Root mean square 
electromyographic recordings 
during MVCs and the submaxi-
mal isometric TTF. A Vastus 
lateralis MVC EMG amplitude. 
B Vastus medialis MVC EMG 
amplitude. C Vastus lateralis 
isometric TTF EMG amplitude. 
D Vastus medialis isometric 
TTF EMG amplitude. *Denotes 
significantly different from 
CTRL (P < 0.05). #Denotes sig-
nificantly different from minute 
1 (P < 0.05)
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time but was greater at minute 1 in HYP (13 [12.4–14.0]) 
compared to CTRL (12 [11–12]) (Wilcoxon P = 0.008) and 
minute 2 (HYP = 15 [15–15.3], CTRL = 14 [13.4–14]) (Wil-
coxon P = 0.024). No difference was seen at task failure 
(CTRL = 20 [20–20]), HYP = 20 [19.8–20]) (Wilcoxon 
P = 1.000).
Pain catastrophising
There was no difference in the sum of pain catastrophising 
score (mean difference = 1.1, 95% CI [− 3.4, 1.1], t11 = 1.13, 
P = 0.281, dz = 0.33).
Discussion
The novel findings of the study are twofold: (i) Increased 
muscle pain reduces endurance performance and maximal 
strength, (ii), these reductions in performance can be attrib-
uted to the excacerbation of central fatigue as seen by greater 
decreases in voluntary activation and a longer silent period 
in HYP compared to CTRL. Furthermore, similar decreases 
in evoked responses were achieved in a shorter time.
Pain on isometric TTF
The intramuscular injection of hypertonic saline prior to 
a submaximal isometric TTF elevated leg muscle pain 
by 36% when conditions were matched for exercise time, 
and pain was particularly exacerbated within the first two 
minutes of exercise in HYP compared to CTRL. This 
increase in leg muscle pain, which was similar in qual-
ity to that of exercise-induced pain (i.e., no difference in 
McGill questionnaire ratings) resulted in a mean 16.2% 
(dz = 1.08) decrease in isometric TTF. These findings are 
similar to other studies which have investigated endurance 
performance in response to pain such as Graven-Nielsen 
et al (1997a, b) who saw a ~ 20% reduction in TTF during 
an isometric dorsiflexion at 80% of maximum torque when 
hypertonic saline was injected into the tibialis anterior and 
Smith et al. (2020) (d = 0.6) who injected hypertonic saline 
into the VL and performed an isometric TTF at 20% of 
maximum torque for the knee extensors. Conversely, no 
difference in TTF at 40% of maximum torque was observed 
when the biceps brachii were injected with hypertonic 
saline (Schulte et al. 2004). Variation in the TTF reducing 
effect is likely a product of the different muscle groups 
tested, chosen exercise intensity and volume/concentra-
tion of hypertonic saline used. A fixed volume of hyper-
tonic saline (1 mL, 5.85%) is also likely to cause a varying 
pain response among individuals (Graven-Nielsen et al. 
1997a) as there are likely differences in pain processing 
among participants (Fillingim 2017). This appeared to be 
the case in the present study as VAS ratings varied greatly 
(see Fig. 2b). This may explain some of the variability in 
changes in TTF in this study as some participants’ mean 
pain was only slightly greater in HYP compared to CTRL. 
Nevertheless, this study demonstrates a notable decrease 
in endurance performance when muscle pain is increased 
in a locomotor muscle which is functionally important for 
common endurance tasks (e.g., running or cycling).
Fig. 5  Pearson correlations 
between the change in pain 
between conditions for the 
first minute of the isometric 
TTF against the difference in 
the change in neuromuscular 
function variables at minute 1. 
A Maximum voluntary force. 
B Voluntary activation level. 
C Doublet amplitude. D EMG 
MVC amplitude of the VL
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Pain and neuromuscular performance
Elevated muscle pain in HYP resulted in a decrease in max-
imum voluntary force at minute 1 and 2 during the TTF 
compared to CTRL. This decrease not only demonstrates 
the ability of pain to reduce maximal strength which has 
been observed by others (Graven-Nielsen et al. 1997b, 2002; 
Slater et al. 2003; Khan et al. 2011) but also represents the 
accentuation in the development of fatigue in HYP com-
pared to CTRL. No difference in end-exercise MVF was 
observed, similar to Smith et al. (2020), despite a marked 
reduction in exercise time. This is reflected by the signifi-
cantly greater ΔMVF/ΔTime in HYP compared to CTRL. 
It is likely that the force-generating capacity is reduced to a 
level which is associated with an inability of the participant 
to maintain sufficient neural drive to maintain target force, 
in line with the theory of the sensory tolerance limit (Hureau 
et al. 2018). During the earlier parts of the TTF, the reduc-
tion in MVF likely reflects a net inhibition of the motor unit 
pool which are used to generate knee extensor forces. Con-
sequently, participants were exercising at the same absolute 
intensity, but a greater relative exercise intensity in HYP 
compared to CTRL.
In combination with measures of MVF was the deliv-
ery of peripheral nerve stimuli during and after each MVC 
which allowed for the quantification of central and periph-
eral fatigue during exercise. Voluntary activation, a meas-
ure of central fatigue, was significantly lower in HYP com-
pared to CTRL at minute 1 which demonstrates the centrally 
mediated reduction in maximum force. No difference was 
observed at minute 2 which is unexpected because the maxi-
mum force was reduced at this time point. It is plausible 
that the interpolated twitch technique which was used to 
calculate voluntary activation may be insensitive to detect 
changes near maximal contraction intensities (Herbert and 
Gandevia 1999). As pain from the saline would have started 
to decrease in some individuals in tandem with an increase 
in naturally occurring exercise-induced pain, the inhibitory 
effect of pain may have been more difficult to capture with 
the ITT at minute 2 compared to minute 1. Furthermore, 
peripheral fatigue was not responsible for the change in 
MVF as the amplitude of the potentiated doublet remained 
unchanged between conditions, suggesting that the hyper-
tonic saline had no impact on excitation–contraction cou-
pling processes.
An interesting and novel finding within the present study 
is that the difference in the mean pain over the first minute 
of exercise between CTRL and HYP had a strong nega-
tive correlation with the difference in the change in MVF 
from baseline to minute 1 (r = − 0.859, P = 0.001) (Fig. 5). 
This was also the case for voluntary activation (r = − 0.773, 
P = 0.013), therefore providing strong evidence that central 
fatigue is mediated by the magnitude of pain perception and 
that pain may act in a ‘dose–response’ effect to cause central 
inhibition. In the present study, it was not possible to discern 
whether this effect is originating from the magnitude of the 
nociceptive signal or whether it is the conscious perception 
of the pain mediating this response, but future work could 
investigate this phenomenon.
Electromyographic responses
There was a reduction in EMG amplitude at minute 1 and 
minute 2 in HYP compared to CTRL for both vasti mus-
cles. This is in agreement with previous experimentally 
induced pain research (Graven-Nielsen et al. 1997b; Rice 
et al. 2019). A reduction in EMG amplitude may reflect a 
reduction in maximal central motor output to the quadriceps, 
that is likely centrally mediated. However, EMG amplitude 
may only provide a crude measure of neural drive (Farina 
et al. 2010) and it is likely that the reduced amplitude is an 
artefact of a reduction in force, as these two variables tend 
to scale linearly (Alkner et al. 2000; Campy et al. 2009). 
Nevertheless, a reduction in force/EMG without a change in 
doublet or M-Wave amplitude strengthens the notion that the 
reduction in force is centrally mediated. The bipolar EMG 
setup precludes the ability to identify which specific neu-
ral mechanisms are responsible for this, although previous 
work using fine-wire intramuscular EMG or high-density 
surface electromyography (HDEMG) during muscle pain 
may provide useful insight (Farina et al. 2004; Tucker et al. 
2009; Martinez-Valdes et al. 2020). A reduction in motor 
unit firing frequency has previously been observed (Farina 
et al. 2004; Tucker et al. 2009) along with a de-recruitment 
of low-threshold motor units (Martinez-Valdes et al. 2020). 
Therefore, the reduction in force and EMG amplitude seen 
in this study may be due to a centrally mediated inhibition 
of motor units and/or a decrease in firing frequency in some 
of the motor units across the motor-neuron pool.
Interestingly, no difference was observed between condi-
tions for submaximal EMG amplitude at minute 1 (when 
hypertonic saline pain was likely evoking the peak-pain 
response) (Fig. 4). It could have been expected that the ear-
lier recruitment of higher threshold motor units to compen-
sate for the pain mediated central inhibition and consequent 
acceleration of fatigue would have led to a greater increase 
in the EMG amplitude with HYP. However as previously 
seen, changes to motor unit firings rates and recruitment 
thresholds have been found without a concomitant change to 
the surface EMG amplitude (Martinez-Valdes et al. 2020). It 
is likely that a combination of excitatory and inhibitory pro-
cesses occur in response to pain (Hodges and Tucker 2011) 
and during exercise the task, the demands can be maintained 
but at the cost of accelerated fatigability. Therefore, com-
plex adjustments to motor control may not be detectable 
by a bipolar surface configuration. Furthermore, evidence 
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suggests that muscle pain may result in a shift in the cen-
tre of gravity of activation (Liew et al. 2019) meaning that 
regional variations in muscle activity may occur, potentially 
outside of the detection volume of the bipolar configuration. 
However, it is not known if a similar change occurs with 
more widespread naturally occurring exercise-induced pain 
as opposed to the more localised muscle pain with hyper-
tonic saline. At the point of task failure, there was a lower 
EMG amplitude in the VL but not the VM in HYP compared 
to CTRL. The reduced EMG amplitude is likely a reflection 
of the shorter TTF and an inability for the individual to rec-
tuit as many high-threshold motor units in HYP which was 
necessary to prolong exercise time.
TMS responses
TMS was delivered during the TTF to determine corticospi-
nal excitability and inhibition in the presence of elevated 
muscle pain. First, corticospinal excitability was not differ-
ent between conditions at any time point and also did not 
change over time. Discrepancies in motor cortex excitabil-
ity in response to acute pain have been observed, with both 
a decrease (Le Pera et al. 2001) and increase (Rice et al. 
2015) in excitability, whereas fatigue from a 2 min MVC 
also increased MEP area but was unchanged with the main-
tenance of group III/IV afferent firing (Kennedy et al. 2016). 
Differences in motor cortical excitability may be related to 
the level of muscle activity present during TMS delivery. 
MEPs evoked at rest appear to show a reduction in corti-
cospinal excitability but not when delivered during an active 
contraction (Burns et al. 2016). Nevertheless, it appears that 
a reduction in corticospinal excitability was not responsible 
for the impaired endurance performance with elevated pain. 
On the other hand, corticospinal inhibition assessed with 
the TMS silent period increased over time and was greater 
at 100 s in HYP compared to CTRL, but not 10 s or at task 
failure. The lack of difference between conditions at 10 s is 
likely due to the lack of time for the saline to reach a level 
of pain which would cause a measurable lengthening of the 
silent period as pain VAS within the beginning of exercise 
was not different between CTRL and HYP (Fig. 2).
The silent period is thought to reflect activity of the 
gamma-aminobutyric acid b neurotransmitter which may 
be acting to inhibit the motor cortical activity, thus poten-
tially impacting motor control and descending drive of the 
quadriceps during the TTF. Additionally, lengthening of the 
TMS silent period can be caused by changes at the spinal 
level which could be elucidated by cervicomedullary evoked 
potentials. Exercise-induced pain or fatigue may therefore 
also act to inhibit spinal motoneurones (Goodall et al. 2018; 
Škarabot et al. 2019). Consistent with these findings, Hilty 
et al. (2011) found that partial blockade of group III/IV 
afferents (including nociceptors) attenuated the lengthening 
of the silent period during exercise. In combination, these 
findings suggest that pain or an increased nociceptive firing 
acts to inhibit the corticospinal pathway and inhibit descend-
ing central drive to the quadriceps.
Task disengagement versus fatigue
One potential mechanism of how pain may have reduced 
endurance performance relates to the aversiveness of pain 
due to the enhanced negative affective-motivational com-
ponent associated with the hypertonic saline injection com-
bined with the intense exercise. This potentially contributes 
to an increased avoidance drive to escape the pain from the 
endurance task (Navratilova and Porreca 2014; Stevens et al. 
2018), and in this study, participants ended the exercise at 
a similar, potentially intolerable level of exercise-induced 
pain. However, end-exercise MVF and doublet amplitude 
were similar and a premature withdrawal from exercise 
would have likely resulted in less end-exercise fatigue. Fur-
thermore, no difference in pain catastrophizing was seen 
between conditions which is associated with exercise per-
formance and task disengagement (Nijs et al. 2008). It is 
plausible that a voluntary task disengagement did occur, but 
this effect was ‘masked’ by the exacerbation of neuromus-
cular fatigue. Furthermore, this ‘voluntary disengagement’ 
effect may be more prevalent in whole-body, longer duration 
exercise, or in non-exercised muscle groups; however, this 
warrants further investigation. Collectively, whilst there is 
not sufficient evidence to rule out task disengagement under 
the present experimental conditions, the differences in neu-
romuscular measures suggest that in this form of exercise 
their impact is greater. We therefore contend that an ampli-
fication of central fatigue best explains the reduction in TTF 
in HYP.
Methodological considerations
Two females took part in the study, however, we did not 
control for what phase they were in of the menstrual cycle 
which may have altered their response to experimental pain 
(Sherman and LeResche 2006) potentially via ‘luteal anal-
gesia’ (Vincent et al. 2018) and exercise performance/neuro-
muscular fatigue (Ansdell et al. 2019; McNulty et al. 2020). 
Future work should attempt to control for this factor.
The TMS stimulus intensity for the MEPs was determined 
by delivering stimuli during contractions at 20% of MVF to 
generate a stimulus–response curve. The lowest intensity to 
to evoke a maximal increase in the VL whilst minimising 
BF MEP was selected (Temesi et al. 2014). We acknowl-
edge that by maximising the MEP amplitude there may be 
a potential for a ‘ceiling effect’ with MEP amplitude. In the 
present study, there was a main effect for time for MEP/
Mmax but subsequent post hoc tests revealed no differences 
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between time points. It was possible that pain may have 
reduced the MEP but fatigue increased it, thus resulting in 
no net difference. Indeed, several other studies using the 
same stimulus intensity method have observed an increase 
in the MEP with fatigue (Pageaux et al. 2015; Kennedy et al. 
2016; Aboodarda et al. 2020). Nevertheless, the utilisation 
of a stimulus intensity at 120% of active motor threshold 
may have provided greater sensetivity for increases in cor-
ticospinal excitability.
The hypertonic saline injected was 1 mL of 5.85% NaCl 
solution. Possibly due to differences in pain threshold and 
pain tolerance, there was a variable response in pain VAS 
to the hypertonic saline injection. One important considera-
tion is those participants who did not report a significant 
increase in pain following the injection of hypertonic saline. 
For example, the difference in mean pain VAS scores when 
normalised for the same exercise time was on average 19 
points greater in HYP compared to CTRL, whereas in three 
participants, it was as low as -4, 3 and 6 units, respectively. 
While this heterogeneous pain response may have allowed 
for a robust correlation analysis, some of the data in changes 
of neuromuscular parameters between CTRL and HYP 
may have become ‘diluted’ with these low responding par-
ticipants. Indeed, work by Graven-Nielsen and colleagues 
(Graven-Nielsen et al. 1997a) demonstrated some individu-
als only rated peak pain as 1 cm on a pain VAS, whereas 
others were around 5–6 cm (out of 10 cm). Future work 
may want to take an individualised approach with injection 
volume to evoke a consistent pain response equal to ‘strong’ 
(~ 5/10 pain VAS).
Conclusion
In summary, elevated muscle pain reduces strength and 
endurance performance due to centrally mediated mecha-
nisms. It is likely that feedback from group III/IV afferent 
nociceptors is responsible for constraining motor output to 
the painful muscle group. A re-distribution/re-organisation 
of motor control may also be acting to maintain the demands 
of the isometric TTF but in a manner that causes fatigue to 
occur more rapidly.
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